Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study

[1]  A. Neugut,et al.  IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. , 2006, Carcinogenesis.

[2]  J. Chang-Claude,et al.  Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study , 2006, British Journal of Cancer.

[3]  D. Altshuler,et al.  IGF-I Genetic Variation and Breast Cancer: the Multiethnic Cohort , 2006, Cancer Epidemiology Biomarkers & Prevention.

[4]  J. Chang-Claude,et al.  Genetic Variation in the Growth Hormone Synthesis Pathway in Relation to Circulating Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Breast Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Study , 2005, Cancer Epidemiology Biomarkers & Prevention.

[5]  I. Ellis,et al.  Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. , 2005, Endocrine-related cancer.

[6]  K. Hemminki,et al.  Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer , 2005, Breast Cancer Research and Treatment.

[7]  J. Ryś,et al.  Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486). , 2005, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[8]  A. Roddam,et al.  A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk , 2005, British Journal of Cancer.

[9]  X. Shu,et al.  Insulin‐like growth factor‐I gene polymorphism and breast cancer risk in Chinese women , 2005, International journal of cancer.

[10]  A. Tjønneland,et al.  Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  M. Bartucci,et al.  Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer. , 2004, Journal of experimental & clinical cancer research : CR.

[12]  X. Shu,et al.  Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[14]  X. Shu,et al.  Evaluation of the synergistic effect of insulin resistance and insulin‐like growth factors on the risk of breast carcinoma , 2004, Cancer.

[15]  A. Schulz,et al.  Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and anti-apoptotic pathways by IGF-I. , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[16]  D. Hunter,et al.  Polymorphic variation at the ‐202 locus in IGFBP3: Influence on serum levels of insulin‐like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk , 2003, International journal of cancer.

[17]  T. Habuchi,et al.  Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer. , 2003, Cancer research.

[18]  F. Horn,et al.  IGFs, basic FGF, and glucose modulate proliferation and apoptosis induced by IFNgamma but not by IL-1beta in rat INS-1E beta-cells. , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[19]  R. Krajcik,et al.  Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  F. Berrino,et al.  Fasting glucose is a risk factor for breast cancer: a prospective study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  F. Speizer,et al.  A sequence repeat in the insulin‐like growth factor‐1 gene and risk of breast cancer , 2002, International journal of cancer.

[22]  Peter H. Westfall,et al.  Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals , 2002, Human Heredity.

[23]  M. Stampfer,et al.  Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. , 2001, The Journal of clinical endocrinology and metabolism.

[24]  R. Shore,et al.  Serum insulin‐like growth factor‐I and breast cancer , 2000, International journal of cancer.

[25]  T. Sellers,et al.  Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer study , 2000, International journal of cancer.

[26]  T. Hansen,et al.  Studies of the variability of the genes encoding the insulin-like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus. , 2000, The Journal of clinical endocrinology and metabolism.

[27]  Y. Wu,et al.  Plasma Insulin-Like Growth Factor-I and Serum IGF-Binding Protein 3 Can Be Associated with the Progression of Breast Cancer, and Predict the Risk of Recurrence and the Probability of Survival in African-American and Hispanic Women , 1999, Oncology.

[28]  C. Mantzoros,et al.  Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. , 1998, Epidemiology.

[29]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[30]  C T Roberts,et al.  Molecular and cellular aspects of the insulin-like growth factor I receptor. , 1995, Endocrine reviews.

[31]  V. Macaulay,et al.  Insulin-like growth factors and cancer. , 1992, British Journal of Cancer.

[32]  M. Johnson,et al.  Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. , 1990, The Journal of biological chemistry.

[33]  R. Humbel,et al.  Insulin-like growth factors I and II. , 1990, European journal of biochemistry.

[34]  P. Rotwein,et al.  Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. , 1989, Endocrine reviews.

[35]  Nicholas J Wareham,et al.  IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. , 2006, Human molecular genetics.

[36]  H. Huynh,et al.  Tamoxifen reduces serum insulin-like growth factor I (IGF-I) , 2005, Breast Cancer Research and Treatment.

[37]  H. Werner,et al.  Molecular and cellular aspects of insulin-like growth factor action. , 1994, Vitamins and hormones.

[38]  J. Bonneterre,et al.  Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. , 1993, European journal of cancer.

[39]  C. Hagen,et al.  Insulinlike Growth Factor Binding Proteins , 1990 .